Tentt

Jubilant Ingrevia Completes 100% Acquisition of Remidex

Closed
HealthcarePlatform

Deal Overview

Jubilant Ingrevia has completed its 100% acquisition of Remidex Pharma Private Limited. The transaction is closed.

The provided deal information does not include financial terms, purchase price, or the specific geographic footprint of Remidex Pharma.

Key Details

Transaction
Jubilant Ingrevia acquires Remidex Pharma

Filed under

Source

Read full article on scanx.trade

via GN - completed acquisition of · March 30, 2026

Powered by Tentt

Source healthcare deals for your firm

Tentt builds and operates managed deal origination services for PE firms, M&A advisors, and commercial lenders. We map the target universe, monitor signals, and execute outreach — white-labelled to your firm.

Book a 30-min intro call

Related Deals

See all Healthcare deals →